Rang	Name	Position
1	Dr. Richard D. Klausner M.D.	Founder & Executive Chairman
2	Dr. Lynn Seely M.D., Ph.D.	Principal Executive Officer, President, CEO & Director
3	Mr. Stephen J. Hill M.B.A.	Chief Operating Officer
4	Dr. Gary K. Lee Ph.D.	Chief Scientific Officer
5	Prof. Stanley R. Riddell M.D.	Founder & Scientific Advisor
6	Dr. Crystal L. Mackall M.D.	Founder & Scientific Advisor
7	Ms. Smital Shah M.B.A.	Principal Financial Officer, CFO & Chief Business Officer
8	Nellie Dillery	Director of Accounting
9	Mr. Mark A. Meltz J.D.	General Counsel & Corporate Secretary
10	Ms. Ann Tomlin	Chief Human Resources Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	ARCH VENTURE CORP	13,25%	38,84 Mio. USD
2	GSK PLC	6,17%	18,09 Mio. USD
3	Orland Properties Ltd	3,08%	9,03 Mio. USD
4	Vanguard Capital Management, LLC	2,93%	8,59 Mio. USD
5	Almitas Capital LLC	2,36%	6,91 Mio. USD
6	Foresite Capital Management V, LLC	1,94%	5,70 Mio. USD
7	Millennium Management LLC	1,50%	4,40 Mio. USD
8	Opaleye Management Inc	1,40%	4,12 Mio. USD
9	venBio Partners LLC	1,38%	4,04 Mio. USD
10	Susquehanna International Group, LLP	1,27%	3,71 Mio. USD
11	Alphabet Inc	1,20%	3,51 Mio. USD
12	BlackRock Inc	0,78%	2,29 Mio. USD
13	Geode Capital Management, LLC	0,68%	2,00 Mio. USD
14	HSG Holding Ltd	0,62%	1,82 Mio. USD
15	Marshall Wace Asset Management Ltd	0,61%	1,78 Mio. USD
16	Renaissance Technologies Corp	0,48%	1,39 Mio. USD
17	The Goldman Sachs Group Inc	0,47%	1,37 Mio. USD
18	Velan Capital Investment Management LP	0,43%	1,26 Mio. USD
19	MIC Capital Management UK LLP	0,36%	1,04 Mio. USD
20	Vanguard Fiduciary Trust Co	0,35%	1,04 Mio. USD